41,42 These cases suggest that melanotan may accelerate melanocytic activity in nevi, although causality remains unproven
Sherry noted that even the companies selling Melanotan II operate without strict regulatory oversight
G lucagon-like peptide 1 receptor agonists (GLP-1RA), a class of medication originally approved for diabetes 1 and now also approved for weight management in patients with obesity, 2 have grown exponentially in popularity over the past few years
Results May Vary: Individual results will vary based on factors including age, baseline condition, lifestyle factors, dietary habits, physical activity levels, consistency of use, genetic factors, current medications, and other individual variables